Related Experiment Video
Updated: Jul 15, 2026

07:44
Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
Published on: March 25, 2022
Predictors of Biliary Drainage Dysfunction Following EUS-Guided Gallbladder Drainage for Malignant Distal Biliary
Summary
Ascites predicts dysfunction in endoscopic ultrasound-guided gallbladder drainage for malignant biliary obstruction. Larger 15-mm stents may reduce adverse events, warranting further study.
Area of Science:
- Gastroenterology
- Interventional Endoscopy
- Oncology
Background:
- Endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) is a key treatment for malignant distal biliary obstruction.
- Predictors of EUS-GBD dysfunction, success, and morbidity are not well-defined.
Purpose of the Study:
- To identify clinical and procedural factors influencing EUS-GBD dysfunction.
- To determine predictors of clinical success and high-grade adverse events.
Main Methods:
- Retrospective, international, multicenter cohort study (March 2017-September 2024).
- 166 patients with malignant distal biliary obstruction undergoing EUS-GBD with lumen-apposing metal stents.
- Analysis of biliary drainage dysfunction, clinical success, and adverse events using Kaplan-Meier and Cox regression.
Main Results:
- High technical (98.8%) and clinical (82.9%) success rates were observed.
- 12-month biliary patency was 70.4%; neither access route nor stent diameter affected patency.
- Ascites was the sole independent predictor of dysfunction (HR 2.45). Cystic duct patency predicted clinical success (OR 2.88). 15-mm stents showed reduced high-grade adverse events (OR 0.31).
Conclusions:
- Ascites is the primary predictor of EUS-GBD dysfunction in malignant biliary obstruction.
- 15-mm stents may offer a safety benefit regarding high-grade morbidity.
- Prospective studies are needed to confirm the role of larger stents in reducing adverse events.
Related Concept Videos
Endoscopic Procedures V: ERCP
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
Patient...
Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...